For every 100 shares of Fortis held, a shareholder will receive 10.83 shares in Manipal Hospitals, the combined company that will be created following the deal, Fortis said.
Fortis, based in Gurugram, also said it approved the sale of a 20 per cent stake in diagnostics chain SRL Ltd to Manipal Hospitals, providing Fortis with more than Rs 700 crore.
Manipal Hospitals will be a publicly-traded company listed on the National Stock Exchange and the Bombay Stock Exchange, while remaining businesses with Fortis Healthcare will be an investment holding company with 36.6 per cent stake in SRL, Fortis said.
Dr Ranjan Pai and US-based private equity firm TPG Capital, a shareholder in Manipal Hospitals since 2015, will invest Rs 3,900 crore in Manipal Hospitals, to finance the acquisition of 50.9 per cent stake in SRL.
Manipal Hospitals is in discussions to buy 30.9 per cent held by other investors in the diagnostics chain.
The investment will also support the proposed acquisition of hospital assets owned by RHT Health Trust and the growth of the hospitals and the diagnostics businesses, Fortis said.
Fortis' main backers, Malvinder Singh and Shivinder Singh, resigned from its board last month following legal troubles related to the sale of their stake in Ranbaxy to Japan's Daiichi Sankyo Co Ltd. The Ranbaxy case is unrelated to Fortis.
"We continue to support the management and the board to successfully transition to the new joint entity," the Singh brothers said in a statement late Tuesday.
© Thomson Reuters 2018